Company
TRIO Pharmaceuticals
Cancer Therapeutics
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
TRIO pharmaceuticals is developing novel dual targeting antibody drugs to treat cancer by reducing toxicity and increasing immune response to fight against cancer more effectively.
Loading relationship preview